Evrofarma SA (ATH:EVROF)

Evrofarma Revenue

In the year 2025, Evrofarma had annual revenue of 49.44M EUR with 8.14% growth. Evrofarma had revenue of 25.12M in the half year ending December 31, 2025, a decrease of -0.32%.

• Revenue: 49.44M
• Revenue Growth: +8.14%
• P/S Ratio: 1.05
• Revenue / Employee: 277.76K
• Employees: 210
• Market Cap: 51.95M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	49.44M	3.72M	8.14%
Dec 31, 2024	45.72M	-3.04M	-6.24%
Dec 31, 2023	48.76M	3.38M	7.45%
Dec 31, 2022	45.38M	8.68M	23.66%
Dec 31, 2021	36.70M	2.79M	8.23%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 18, 2026

Data Sources Report a data error